{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:38:10Z","timestamp":1788878290839,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.04.014","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T06:06:23Z","timestamp":1525068383000},"page":"2928-2936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus"],"prefix":"10.1016","volume":"36","author":[{"given":"Leonardo","family":"G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Betancur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"O\u00f1ate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2018.04.014_b0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijantimicag.2010.06.013","article-title":"The changing Brucella ecology: novel reservoirs, new threats","volume":"36","author":"Pappas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0010","first-page":"1","article-title":"Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics","volume":"2","author":"He","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.014_b0015","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ajpath.2015.03.003","article-title":"Pathogenesis and immunobiology of brucellosis review of Brucella\u2013host interactions","volume":"185","author":"de Figueiredo","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2018.04.014_b0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev-micro-090110-102905","article-title":"Interactions of the human pathogenic Brucella species with their hosts","volume":"65","author":"Atluri","year":"2011","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.014_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00430-009-0123-8","article-title":"Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host\u201d","volume":"198","author":"Roop","year":"2009","journal-title":"Med Microbiol Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2018.04.014_b0030","doi-asserted-by":"crossref","first-page":"e1929","DOI":"10.1371\/journal.pntd.0001929","article-title":"Clinical manifestations of human brucellosis: a systematic review and meta-analysis","volume":"6","author":"Dean","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tvjl.2009.04.010","article-title":"Pathogenesis of bovine brucellosis","volume":"184","author":"Carvalho","year":"2010","journal-title":"Vet J"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.prevetmed.2011.04.007","article-title":"Brucellosis at the animal\/ecosystem\/human interface at the beginning of the 21st century","volume":"102","author":"Godfroid","year":"2011","journal-title":"Prev Vet Med"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.014_b0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1586\/14760584.4.6.915","article-title":"Essential role of vaccines in brucellosis control and eradication programs for livestock","volume":"4","author":"Olsen","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.014_b0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10408419009105726","article-title":"Pathogenesis of Brucella","volume":"17","author":"Smith","year":"1990","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.014_b0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front Biol (Beijing)"},{"issue":"1\u20134","key":"10.1016\/j.vaccine.2018.04.014_b0060","first-page":"1","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.04.014_b0065","doi-asserted-by":"crossref","unstructured":"Paquali P, Adone R, Gasbarre L, et al. Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection. Infec Immun 2001;69(10):6541\u201344.","DOI":"10.1128\/IAI.69.10.6541-6544.2001"},{"issue":"9","key":"10.1016\/j.vaccine.2018.04.014_b0070","doi-asserted-by":"crossref","first-page":"e0136696","DOI":"10.1371\/journal.pone.0136696","article-title":"Immune response of calves vaccinated with Brucella abortus S19 or RB51 and revaccinated with RB51","volume":"10","author":"Dorneles","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2018.04.014_b0075","doi-asserted-by":"crossref","first-page":"e0166582","DOI":"10.1371\/journal.pone.0166582","article-title":"Meta-analysis and advancement of brucellosis vaccinology","volume":"11","author":"Carvalho","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.014_b0080","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/IAI.01433-09","article-title":"The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice","volume":"78","author":"Trant","year":"2010","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2018.04.014_b0085","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/IAI.71.11.6264-6269.2003","article-title":"Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine","volume":"71","author":"Ugalde","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.014_b0090","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.vaccine.2009.10.113","article-title":"znuA purE Brucella abortus 2308 mutant as a live vaccine candidate","volume":"28","author":"Yang","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.014_b0095","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4142\/jvs.2015.16.4.467","article-title":"Immunization of BALB\/c mice with Brucella abortus 2308\u0394wbkA confers protection against wild-type infection","volume":"16","author":"Li","year":"2015","journal-title":"J Vet Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/IAI.01017-08","article-title":"The Brucella abortus S19 vjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB\/c mice when delivered in a sustained-release vehicle","volume":"77","author":"Arenas-Gamboa","year":"2009","journal-title":"Infect Immun"},{"issue":"30","key":"10.1016\/j.vaccine.2018.04.014_b0105","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1016\/j.vaccine.2006.11.058","article-title":"Biological safety concepts of genetically modified live bacterial vaccines","volume":"25","author":"Frey","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2018.04.014_b0110","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1\u2013Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2018.04.014_b0115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/L12 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Oliveira","year":"1996","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2018.04.014_b0120","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxy nucleotides as adjuvant","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"issue":"37\u201338","key":"10.1016\/j.vaccine.2018.04.014_b0125","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.014_b0130","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2012.02.126","article-title":"Intradermal immunization with outer membrane protein 25 protects BALB\/c mice from virulent B. abortus 544","volume":"51","author":"Goel","year":"2012","journal-title":"Mol Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.014_b0140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1292\/jvms.11-0512","article-title":"Evaluation of recombinant 28 kDa outer membrane protein of Brucella abortus for the clinical diagnosis of bovine brucellosis in Korea","volume":"74","author":"Lim","year":"2012","journal-title":"J Vet Med Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11259-009-9337-x","article-title":"Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant Omp28 adjuvanted with CpG oligonucleotides","volume":"34","author":"Kaushik","year":"2010","journal-title":"Vet Res Commun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.04.014_b0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vetmic.2012.07.016","article-title":"Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB\/c mice","volume":"161","author":"Li","year":"2012","journal-title":"Vet Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2018.04.014_b0155","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.014_b0160","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2018.04.014_b0165","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1128\/IAI.71.9.4857-4861.2003","article-title":"A DNA Vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB\/c mice","volume":"71","author":"O\u00f1ate","year":"2003","journal-title":"Infect Immun"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2018.04.014_b0170","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0264-410X(97)00140-0","article-title":"Nucleic acid vaccination of Brucella abortus ribosomal L7\/L12 gene elicits immune response","volume":"15","author":"Kurar","year":"1997","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.014_b0175","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2018.04.014_b0180","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/IAI.69.10.6264-6270.2001","article-title":"\u201cInduction of immune response in BALB\/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.014_b0185","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/dna.2006.0552","article-title":"A combined DNA vaccine encoding BCSP31, SOD, and L7\/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses","volume":"26","author":"Yu","year":"2007","journal-title":"DNA Cell Biol"},{"issue":"35","key":"10.1016\/j.vaccine.2018.04.014_b0190","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1016\/j.vaccine.2014.06.012","article-title":"Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB\/c mice","volume":"32","author":"Jain","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.014_b0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1286-4579(00)01350-2","article-title":"Immunity and protection against Brucella abortus","volume":"3","author":"Golding","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2018.04.014_b0200","series-title":"Brucella: molecular microbiology and genomics","first-page":"36","article-title":"The Brucella genomic island","author":"Mancilla","year":"2011"},{"issue":"13","key":"10.1016\/j.vaccine.2018.04.014_b0205","first-page":"1","article-title":"Molecular targets for rapid identification of Brucella spp","volume":"6","author":"Ratushna","year":"2006","journal-title":"BMC Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.04.014_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetmic.2011.09.025","article-title":"Roles of genomic island 3 (GI-3) BAB1_0278 and BAB1_0263 open reading frames (ORFs) in the virulence of Brucella abortus in BALB\/c mice","volume":"156","author":"C\u00e9spedes","year":"2012","journal-title":"Vet Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.04.014_b0215","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.vetmic.2014.05.005","article-title":"Roles of genomic island 3 (GI-3) BAB1_0267 and BAB1_0270 open reading frames (ORFs) in the virulence of Brucella abortus 2308","volume":"172","author":"Ortiz-Rom\u00e1n","year":"2014","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0220","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.ppat.0040021","article-title":"Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1","volume":"4","author":"Salcedo","year":"2008","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0225","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1574-6976.2008.00136.x","article-title":"Genomic islands: tools of bacterial horizontal gene transfer and evolution","volume":"33","author":"Juhas","year":"2009","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.014_b0230","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nm1734","article-title":"Subversion of Toll-like receptor signaling by a unique family of bacterial Toll\/interleukin-1 receptor domain\u2013containing proteins","volume":"14","author":"Cirl","year":"2008","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.014_b0235","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbrc.2016.06.064","article-title":"Brucella TIR-like protein TcpB\/Btp1 specifically targets the host adaptor protein MAL\/TIRAP to promote infection","volume":"477","author":"Li","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2018.04.014_b0240","doi-asserted-by":"crossref","unstructured":"Ke Y, Wang Y, Li W, et al. Type IV secretion system of Brucella spp. and its effectors. Front Cell Infect Microbiol 2015;5(72):1\u201310.","DOI":"10.3389\/fcimb.2015.00072"},{"issue":"12","key":"10.1016\/j.vaccine.2018.04.014_b0245","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.tim.2015.09.007","article-title":"Brucella abortus cell cycle and infection are coordinated","volume":"23","author":"De Bolle","year":"2015","journal-title":"Trends Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.014_b0250","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1462-5822.2005.00502.x","article-title":"The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection","volume":"7","author":"Fretin","year":"2005","journal-title":"Cell Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0255","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/jmbi.2001.4963","article-title":"The role in flagellar rod assembly of the N-terminal domain of Salmonella FlgJ, a flagellum specific muramidase","volume":"312","author":"Hirano","year":"2001","journal-title":"J Mol Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.014_b0260","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1128\/JB.181.5.1555-1561.1999","article-title":"Peptidoglycan-hydrolyzing activity of the FlgJ protein, essential for flagellar rod formation in Salmonella typhimurium\u201d","volume":"181","author":"Nambu","year":"1999","journal-title":"J Bacteriol"},{"issue":"50","key":"10.1016\/j.vaccine.2018.04.014_b0265","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1016\/j.vaccine.2012.09.039","article-title":"\u201cEvaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB\/c mice","volume":"30","author":"Sislema-Egas","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0270","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/JB.188.2.633-641.2006","article-title":"Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis","volume":"188","author":"Chen","year":"2006","journal-title":"J Bacteriol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.014_b0275","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1371\/journal.ppat.0030087","article-title":"Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis\u201d","volume":"3","author":"Colangeli","year":"2007","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.vaccine.2018.04.014_b0280","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/nar\/gkm1162","article-title":"Lsr2 of Mycobacterium tuberculosis is a DNA-bridging protein","volume":"36","author":"Chen","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.014_b0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/138920308784534014","article-title":"Extracellular SH3 domain containing proteins features of a new protein family","volume":"9","author":"Stoll","year":"2008","journal-title":"Curr Protein Pept Sci"},{"issue":"21","key":"10.1016\/j.vaccine.2018.04.014_b0290","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1093\/emboj\/cdf558","article-title":"GW domains of the Listeria monocytogenes invasion protein InlB are SH3-like and mediate binding to host ligands","volume":"21","author":"Marino","year":"2002","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.014_b0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0962-8924(99)01681-5","article-title":"No longer an exclusive club: eukaryotic signaling domains in bacteria","volume":"10","author":"Bakal","year":"2010","journal-title":"Trends Cell Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.014_b0300","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0968-0004(99)01366-3","article-title":"SH3 domains in prokaryotes","volume":"24","author":"Whisstock","year":"1999","journal-title":"Trends Biochem Sci"},{"issue":"117","key":"10.1016\/j.vaccine.2018.04.014_b0305","first-page":"1","article-title":"Immunogenicity and protective response induced by recombinant plasmids based on the BAB1_0267 and BAB1_0270 open reading frames of Brucella abortus 2308 in BALB\/c mice","volume":"6","author":"G\u00f3mez","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.014_b0310","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2958.2008.06414.x","article-title":"A conserved anti-repressor controls horizontal gene transfer by proteolysis","volume":"70","author":"Bose","year":"2008","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.014_b0315","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/mmi.12774","article-title":"Radiation response in Deinococcus deserti: IrrE is a metalloprotease that cleaves repressor protein DdrO","volume":"94","author":"Ludanyi","year":"2014","journal-title":"Mol Microbiol"},{"issue":"52","key":"10.1016\/j.vaccine.2018.04.014_b0320","first-page":"1","article-title":"The diversity and evolution of cell cycle regulation in alpha-proteobacteria: a comparative genomic analysis","volume":"4","author":"Brilli","year":"2010","journal-title":"BMC Syst Biol"},{"issue":"36","key":"10.1016\/j.vaccine.2018.04.014_b0325","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/j.vaccine.2013.06.013","article-title":"Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB\/c mice","volume":"31","author":"Riquelme-Neira","year":"2013","journal-title":"Vaccine"},{"issue":"125","key":"10.1016\/j.vaccine.2018.04.014_b0330","first-page":"1","article-title":"Immunogenicity of a multi-epitope DNA vaccine encoding epitopes from Cu\u2013Zn superoxide dismutase and open reading frames of Brucella abortus in mice\u201d","volume":"8","author":"Escalona","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.04.014_b0335","doi-asserted-by":"crossref","first-page":"6535479","DOI":"10.1155\/2017\/6535479","article-title":"Multivalent fusion DNA Vaccine against Brucella abortus","volume":"2017","author":"G\u00f3mez","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2018.04.014_b0340","doi-asserted-by":"crossref","unstructured":"Hunt J, Brown L, Jackson D. Antigenic competition. In: Encyclopedia of Life Sciences, Chichester (UK): John Wiley & Sons Ltd; 2001: p. 1\u20136.","DOI":"10.1038\/npg.els.0000948"},{"issue":"31","key":"10.1016\/j.vaccine.2018.04.014_b0345","first-page":"1","article-title":"Immunogenicity of infectious pathogens and vaccine antigens","volume":"16","author":"Mahanty","year":"2015","journal-title":"BMC Immunol"},{"key":"10.1016\/j.vaccine.2018.04.014_b0350","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coi.2017.06.005","article-title":"Old and new adjuvants","volume":"47","author":"McKee","year":"2017","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.014_b0355","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.vaccine.2014.11.056","article-title":"Brucella abortus S19 and RB51 vaccine immunogenicity test: evaluation of three mice (BALB\/c, Swiss and CD-1) and two challenge strains (544 and 2308)","volume":"33","author":"Miranda","year":"2015","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2018.04.014_b0360","first-page":"1","article-title":"What have we learned from brucellosis in the mouse model?","volume":"43","author":"Grill\u00f3","year":"2012","journal-title":"BMC Vet Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:26:11Z","timestamp":1759400771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18304833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":72,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X18304833"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}